Alltrna Stock

Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.

Sign up today and learn more about Alltrna Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Alltrna Stock

Alltrna is the tRNA platform company to decipher tRNA biology and pioneer tRNA therapeutics to treat thousands of diseases. tRNAs play a central role in the translation of mRNA into proteins. tRNA biology modulates the complex code of DNA and RNA across translation and transcription. Altrna platform incorporates AI/ML tools to learn the tRNA language and deliver diverse programmable molecules with broad therapeutic potential.

Funding History

November 2021$50.0M
August 2023$109M


VP, Medical and Regulatory Affairs

Anne Pariser

Chief Financial Officer

Joanne Protano

Board Member

Noubar Afeyan

Board Member

Lovisa Afzelius

Co-founder and Chief Innovation Officer

Theonie Anastassiadis


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: